Radnet, Inc. operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Radnet with three other
pharmaceutical manufacturers in North America:
Opko Health Incorporation
sales of $990.27 million
of which 82%
of which 100%
was Buprenorphine Based Drugs).
During the year ended December of 2018, sales at
Radnet were $975.15 million.
increase of 5.7%
versus 2017, when the company's sales were $922.19 million.
This was the fifth consecutive year of sales increases at Radnet
(and since 2013, sales have increased a total of 39%).